Feb 15, 2021 | Life Sciences, Portfolio Companies
ACS – “Amy Ripka is CEO of Lucy Therapeutics, a Boston-based, mitochondrial platform biotech, revolutionizing treatments for rare and neurological diseases. Previous to her role at LucyTx, she served on the executive leadership teams at SAI Life Sciences...
Feb 11, 2021 | Safar News
We are very excited to have Sophie join Safar’s Scientific Advisory Board! We are confident Sophie will be a strong asset for our growing portfolio of cleantech and material science, as well as AI and IT companies. Sophie Vandebroek is founder and owner of Strategic...
